44 results on '"Han, Sangdon"'
Search Results
2. Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist
3. Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinism
4. Discovery of Paltusotine (CRN00808), a Potent, Selective, and Orally Bioavailable Non-peptide SST2 Agonist.
5. Discovery of nonpeptide 3,4-dihydroquinazoline-4-carboxamides as potent and selective sst2 agonists
6. Effects of CRN04894, a Nonpeptide Orally Bioavailable ACTH Antagonist, on Corticosterone in Rodent Models of ACTH Excess
7. GPR41/FFAR3 and GPR43/FFAR2 as Cosensors for Short-Chain Fatty Acids in Enteroendocrine Cells vs FFAR3 in Enteric Neurons and FFAR2 in Enteric Leukocytes
8. Chapter 11 Recent Advances in the Discovery of CB2 Selective Agonists
9. The Structure and Thermal Stability of 1,2-Dimethoxycarbonyl-3,3-dimethylcyclopropene
10. Rearrangements of 3-aryl-substituted cyclopropenyl anions and the gas-phase acidity of 3-(4-methylphenyl)cyclopropene
11. MON-176 Discovery and Identification of Late Stage Selective Nonpeptide ACTH Antagonists for the Treatment of Cushing’s Disease, Ectopic ACTH Secreting Tumors, and Congenital Adrenal Hyperplasia
12. SAT-364 Nonpeptide Orally-Bioavailable ACTH Antagonists: Suppression of ACTH-Induced Corticosterone Secretion and Adrenal Hypertrophy in Rats
13. The gas-phase acidity of cyclopropene and simple alkyl derivatives: can they be measured?
14. Embelin and its derivatives unravel the signaling, proinflammatory and antiatherogenic properties of GPR84 receptor
15. Discovery of APD371: Identification of a Highly Potent and Selective CB2 Agonist for the Treatment of Chronic Pain
16. Discovery of a novel trans-1,4-dioxycyclohexane GPR119 agonist series
17. Design and synthesis of new tricyclic indoles as potent modulators of the S1P1 receptor
18. Discovery of 1a,2,5,5a-tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalen-4-carboxamides as potent and selective CB2 receptor agonists
19. Discovery and optimization of 5-fluoro-4,6-dialkoxypyrimidine GPR119 agonists
20. Fused tricyclic indoles as S1P1 agonists with robust efficacy in animal models of autoimmune disease
21. Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P 1 agonists
22. Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor
23. GPR41/FFAR3 and GPR43/FFAR2 as Cosensors for Short-Chain Fatty Acids in Enteroendocrine Cells vs FFAR3 in Enteric Neurons and FFAR2 in Enteric Leukocytes
24. Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: In vitro profiling and in vivo evaluation
25. Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
26. GPR119 agonists 2009–2011
27. Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P1 agonists
28. ChemInform Abstract: Cyclopentadienylcobalt-Mediated Intermolecular Cycloaddition of α,ω-Diynes to (Cyclo)alkenes: Synthesis of Linearly Fused Oligocycles and Extension to Enantiomerically Pure (6aR,10aR)-Dihydroanthracyclinones.
29. Cyclopentadienylcobalt-Mediated Intermolecular Cycloaddition of α,ω-Diynes to (Cyclo)alkenes: Synthesis of Linearly Fused Oligocycles and Extension to Enantiomerically Pure (6aR,10aR)-Dihydroanthracyclinones
30. Total Syntheses and Structures of Angular [6]- and [7]Phenylene: The First Helical Phenylenes (Heliphenes)
31. Cover Picture: Angew. Chem. Int. Ed. 17/2002
32. Total Syntheses of Angular [7]-, [8]-, and [9]Phenylene by Triple Cobalt-Catalyzed Cycloisomerization: Remarkably Flexible Heliphenes
33. Titelbild: Angew. Chem. 17/2002
34. Rearrangements of 3-Aryl-Substituted Cyclopropenyl Anions and the Gas-Phase Acidity of 3-(4-Methylphenyl)cyclopropene
35. ChemInform Abstract: Synthesis of 3‐Aryl‐3‐trimethylsilylcyclopropenes and Their Dibenzoyl Derivatives. Possible Cyclopropenyl Anion Precursors?
36. Synthesis of 3-aryl-3-trimethylsilylcyclopropenes and their dibenzoyl derivatives. Possible cyclopropenyl anion precursors? †
37. Thermal rearrangements of 7,7-dihalo-trans-bicyclo[4.1.0]hept-3-enes
38. The Synthesis of Potential Cyclopropenyl Anion Precursors: 3-Methyl-3-trimethylsilylcyclopropene and Its Dibenzoyl Derivative
39. TherapeuticUtility of Cannabinoid Receptor Type 2 (CB2) SelectiveAgonists.
40. Fused tricyclic indoles as S1P1 agonists with robust efficacy in animal models of autoimmune disease
41. Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P1 agonists
42. Chapter 11 Recent Advances in the Discovery of CB2 Selective Agonists.
43. Hindered rotation in an "exploded" biphenyl.
44. Discovery of APD371: Identification of a Highly Potent and Selective CB 2 Agonist for the Treatment of Chronic Pain.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.